Trial And Error: India Sets Compensation Rules For Clinical Trial Victims; Warns Cancellation In Cases Of Violations
This article was originally published in PharmAsia News
Executive Summary
A government notification laid down a structured compensation plan for clinical trial victims. The move aims to tighten rules for clinical trials in an industry under attack from health activists and blamed for deficiencies and compromising patient safety.